The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.
Scientists have uncovered a surprising new healing mechanism in injured cells called cathartocytosis, in which cells "vomit" out their internal machinery to revert more quickly to a stem cell-like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback